A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)

计划入组 146 人 · 首次发布于 2018 年 8 月 23 日

Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease

计划入组 14 人 · 首次发布于 2018 年 6 月 1 日

Desensitization in Kidney Transplantation

计划入组 44 人 · 首次发布于 2009 年 5 月 27 日

Allogeneic B7.1/HLA-A1

HLA-A2402/HLA-A0201 restricted epitope peptide vaccine

HLA-binding peptides vaccine

HLT, Inc.

United States

LABORATOIRE HRA PHARMA

Spain

Ela Medical Inc

United States

Topas Therapeutics to Present Promising Phase 2a Data for Novel Celiac Disease Treatment at DDW 2025

Revolutionary Blood Test Enables Celiac Disease Diagnosis Without Gluten Challenge

Chinese Researchers Discover Novel HLA Allele HLA-DQB1*03:03:38 with Clinical Promise